BRIEF-Cynapsus therapeutics signs global licensing agreement with Monosol RX
April 4 (Reuters) - Cynapsus Therapeutics Inc :
* Cynapsus Therapeutics and Monosol RX announce global IP licensing agreement
* Signed a global licensing agreement for certain intellectual property with Monosol RX
* Under agreement, Monosol RX will receive up front and contingent milestone payments, single-digit royalty payments on net sales of apl-130277 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.